Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-29

Clinical Trial Update: Plan D- Vitamin D Supplementation in Psychotic Disorders [NA]

View source ↗

Summary

A completed clinical trial evaluating vitamin D supplementation in individuals with schizophrenia spectrum and other psychotic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Schizophrenia Spectrum and Other Psychotic Disorders | NA | Status: COMPLETED